Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NeoFuse (Mesoblast Ltd)
- Development stage
- Unknown
- Lead developer
- Mesoblast
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Implant
01
Overview
NeoFuse is an investigational regenerative medicine product developed by Mesoblast for use in posterolateral lumbar fusion (PLF) procedures. It consists of allogeneic Mesenchymal Precursor Cells (MPCs), which are stem cell-based biologics, combined with MasterGraft Granules, a ceramic bone scaffold. The therapy is designed to promote bone regeneration and spinal fusion in patients with degenerative disc disease (DDD), degenerative spondylolisthesis, or spinal stenosis. By leveraging the osteogenic and regenerative properties of MPCs, NeoFuse aims to provide a reliable alternative to autologous bone grafts, thereby eliminating the need for a second surgical procedure to harvest bone from the patient's iliac crest.
- Brand names
- NeoFuse
- Other names
- PLF with NeoFuseNeoFuse with MasterGraft GranulesMPC-06-IDMPC06-IDMPC 06-ID
Beyond the preview
Go deeper on NeoFuse (Mesoblast Ltd).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoFuse (Mesoblast Ltd).